Compare · CTSH vs IQV
CTSH vs IQV
Side-by-side comparison of Cognizant Technology Solutions Corporation (CTSH) and IQVIA Holdings Inc. (IQV): market cap, price performance, sector, and recent activity on the wire.
Summary
- CTSH operates in Technology, while IQV operates in Health Care - the two are in different parts of the market.
- IQV is the larger of the two at $42.78B, about 1.6x CTSH ($26.67B).
- Over the past year, CTSH is down 10.0% and IQV is up 28.7% - IQV leads by 38.7 points.
- CTSH has been more active in the news (13 items in the past 4 weeks vs 5 for IQV).
- Both have 25 recent analyst ratings on file.
- Company
- Cognizant Technology Solutions Corporation
- IQVIA Holdings Inc.
- Price
- $59.68+0.83%
- $262.25+0.94%
- Market cap
- $26.67B
- $42.78B
- 1M return
- -0.54%
- +0.09%
- 1Y return
- -10.03%
- +28.70%
- Industry
- EDP Services
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NYSE
- IPO
- 1998
- 2013
- News (4w)
- 13
- 5
- Recent ratings
- 25
- 25
Cognizant Technology Solutions Corporation
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. The company operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. It offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; and enhanced compliance, integrated health management, claims investigative services, and patient experience, as well as services that drive operational improvements in areas, such as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. The company also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and cloud, interactive, and IoT services to information, media and entertainment, and communications and technology companies. Cognizant Technology Solutions Corporation was founded in 1994 and is headquartered in Teaneck, New Jersey.
IQVIA Holdings Inc.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Latest CTSH
- 80% of Employees Want to Use AI More Than Their Jobs Allow
- SEC Form 8-K filed by Cognizant Technology Solutions Corporation
- Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences
- Belcan Receives Pratt & Whitney Premier Awards for Overall Excellence in Business Management and Technology & Innovation
- Cognizant Selected by SITA to Deliver AI-Led Global Finance Transformation on the Cloud
- SEC Form 4 filed by Cognizant Technology Solutions Corporation
- Cognizant Launches Cognizant Activate to Bring Enterprise AI Transformation for Emerging Enterprises
- SVP, Controller & CAO Kerdman Alina sold $7,906 worth of shares (139 units at $56.88) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 1,124 units (SEC Form 4)
- Cognizant Schedules Third Quarter 2026 Earnings Release and Conference Call
- Cognizant Named to Forbes World's Best Employers 2026 List
Latest IQV
- IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions
- IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
- UBS resumed coverage on IQVIA with a new price target
- IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026
- IQVIA Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- SEC Form 8-K filed by IQVIA Holdings Inc.
- IQVIA Announces Pricing of Senior Notes
- IQVIA Announces Offering of Senior Notes
- Officer Berkshire James G. exercised 5,381 shares at a strike of $131.82, sold $697,228 worth of shares (2,668 units at $261.33) and returned $709,558 worth of shares to the company (2,713 units at $261.54) (SEC Form 4)
- IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster